Fukashi Ishibashi

1.1k total citations
56 papers, 810 citations indexed

About

Fukashi Ishibashi is a scholar working on Molecular Biology, Physiology and Surgery. According to data from OpenAlex, Fukashi Ishibashi has authored 56 papers receiving a total of 810 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 15 papers in Physiology and 13 papers in Surgery. Recurrent topics in Fukashi Ishibashi's work include Pancreatic function and diabetes (12 papers), Metabolism, Diabetes, and Cancer (9 papers) and Retinal Diseases and Treatments (8 papers). Fukashi Ishibashi is often cited by papers focused on Pancreatic function and diabetes (12 papers), Metabolism, Diabetes, and Cancer (9 papers) and Retinal Diseases and Treatments (8 papers). Fukashi Ishibashi collaborates with scholars based in Japan, United Kingdom and United States. Fukashi Ishibashi's co-authors include Mitra Tavakoli, Miki Taniguchi, Barbara V. Howard, Asami Kawasaki, Rie Kojima, Angela C. Shore, Hassan Fadavi, Hideki Hidaka, B. V. Howard and Hideaki Kaneto and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Clinical Endocrinology & Metabolism and Diabetes Care.

In The Last Decade

Fukashi Ishibashi

54 papers receiving 769 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fukashi Ishibashi Japan 16 229 183 173 143 136 56 810
Amey Holmes United States 18 307 1.3× 96 0.5× 218 1.3× 61 0.4× 55 0.4× 20 935
R. Nagai Japan 15 134 0.6× 208 1.1× 192 1.1× 178 1.2× 130 1.0× 25 962
Toshihide Oizumi Japan 23 302 1.3× 361 2.0× 342 2.0× 292 2.0× 298 2.2× 43 1.5k
P. H. N. Oomen Netherlands 10 168 0.7× 387 2.1× 102 0.6× 53 0.4× 55 0.4× 16 1.0k
Cynthia K. Silbert United States 19 267 1.2× 391 2.1× 379 2.2× 19 0.1× 33 0.2× 30 1.3k
Takeyoshi Murano Japan 24 265 1.2× 418 2.3× 292 1.7× 44 0.3× 41 0.3× 52 1.2k
Tetsuyuki Yasuda Japan 20 151 0.7× 515 2.8× 319 1.8× 30 0.2× 39 0.3× 47 1.2k
MASAEI KAKIZAKI Japan 12 308 1.3× 237 1.3× 328 1.9× 28 0.2× 26 0.2× 14 986
Yehong Yang China 18 138 0.6× 352 1.9× 242 1.4× 28 0.2× 24 0.2× 60 958
Bianca Marmontel de Souza Brazil 19 558 2.4× 160 0.9× 497 2.9× 46 0.3× 39 0.3× 41 1.4k

Countries citing papers authored by Fukashi Ishibashi

Since Specialization
Citations

This map shows the geographic impact of Fukashi Ishibashi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fukashi Ishibashi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fukashi Ishibashi more than expected).

Fields of papers citing papers by Fukashi Ishibashi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fukashi Ishibashi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fukashi Ishibashi. The network helps show where Fukashi Ishibashi may publish in the future.

Co-authorship network of co-authors of Fukashi Ishibashi

This figure shows the co-authorship network connecting the top 25 collaborators of Fukashi Ishibashi. A scholar is included among the top collaborators of Fukashi Ishibashi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fukashi Ishibashi. Fukashi Ishibashi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ishibashi, Fukashi, et al.. (2022). Sodium Glucose Cotransporter-2 Inhibitor Protects Against Diabetic Neuropathy and Nephropathy in Modestly Controlled Type 2 Diabetes: Follow-Up Study. Frontiers in Endocrinology. 13. 864332–864332. 11 indexed citations
2.
Fadavi, Hassan, Fukashi Ishibashi, Susan J. Howard, et al.. (2022). Implementation of corneal confocal microscopy for screening and early detection of diabetic neuropathy in primary care alongside retinopathy screening: Results from a feasibility study. Frontiers in Endocrinology. 13. 891575–891575. 7 indexed citations
3.
4.
Fadavi, Hassan, et al.. (2021). Advances in Screening, Early Diagnosis and Accurate Staging of Diabetic Neuropathy. Frontiers in Endocrinology. 12. 671257–671257. 88 indexed citations
5.
Ishibashi, Fukashi, et al.. (2013). Correlation between sudomotor function, sweat gland duct size and corneal nerve fiber pathology in patients with type 2 diabetes mellitus. Journal of Diabetes Investigation. 5(5). 588–596. 27 indexed citations
6.
Ishibashi, Fukashi, et al.. (2013). Morphometric features of corneal epithelial basal cells, and their relationship with corneal nerve pathology and clinical factors in patients with type 2 diabetes. Journal of Diabetes Investigation. 4(5). 492–501. 13 indexed citations
7.
Katakami, Naoto, Hideaki Kaneto, Taka‐aki Matsuoka, et al.. (2011). Adiponectin G276T gene polymorphism is associated with cardiovascular disease in Japanese patients with type 2 diabetes. Atherosclerosis. 220(2). 437–442. 23 indexed citations
8.
Katakami, Naoto, Hideaki Kaneto, Takeshi Osonoi, et al.. (2011). Transforming growth factor β1 T868C gene polymorphism is associated with cerebral infarction in Japanese patients with type 2 diabetes. Diabetes Research and Clinical Practice. 94(3). e57–e60. 6 indexed citations
9.
Ishibashi, Fukashi, et al.. (2011). Corneal nerve fiber pathology in Japanese type 1 diabetic patients and its correlation with antecedent glycemic control and blood pressure. Journal of Diabetes Investigation. 3(2). 191–198. 42 indexed citations
10.
Katakami, Naoto, Hideaki Kaneto, Taka‐aki Matsuoka, et al.. (2010). Accumulation of gene polymorphisms related to oxidative stress is associated with myocardial infarction in Japanese type 2 diabetic patients. Atherosclerosis. 212(2). 534–538. 25 indexed citations
11.
Katakami, Naoto, Munehide Matsuhisa, Hideaki Kaneto, et al.. (2010). Monocyte chemoattractant protein-1 (MCP-1) gene polymorphism as a potential risk factor for diabetic retinopathy in Japanese patients with type 2 diabetes. Diabetes Research and Clinical Practice. 89(1). e9–e12. 27 indexed citations
12.
Katakami, Naoto, Kenya Sakamoto, Hideaki Kaneto, et al.. (2009). Combined effect of oxidative stress-related gene polymorphisms on atherosclerosis. Biochemical and Biophysical Research Communications. 379(4). 861–865. 22 indexed citations
13.
Ishibashi, Fukashi. (2005). Chronic high glucose inhibits albumin reabsorption by lysosomal alkalinization in cultured porcine proximal tubular epithelial cells (LLC-PK1). Diabetes Research and Clinical Practice. 72(3). 223–230. 4 indexed citations
14.
Ishibashi, Fukashi. (1993). Glomerular clearance and tubular reabsorption of IgG1 and IgG4 in microalbuminuric patients with non-insulin-dependent diabetes mellitus (NIDDM). Diabetes Research and Clinical Practice. 22(1). 45–51. 6 indexed citations
15.
Ishibashi, Fukashi. (1992). Increased Urinary Transferrin Excretion in Non-Insulin-Dependent Diabetes Mellitus (NIDDM). 35(12). 949–954.
16.
Ishibashi, Fukashi, et al.. (1991). Comparison of renal hemodynamics in early non-insulin-dependent and insulin-dependent diabetes mellitus. Journal of Diabetic Complications. 5(2-3). 143–145. 15 indexed citations
17.
Ishibashi, Fukashi, Hideki Hidaka, & Barbara V. Howard. (1982). Glucose Enhancement of Insulin Action: Elevated Glucose Levels Increase Insulin Stimulation of 2-Deoxyglucose Uptake in Cultured Human Fibroblasts*. The Journal of Clinical Endocrinology & Metabolism. 54(1). 34–39. 20 indexed citations
18.
Ishibashi, Fukashi, Paul Bennett, & B. V. Howard. (1981). Alloxan action on glucose metabolism in cultured fibroblasts. II. Effects on pentose-monophosphate shunt and tricarboxylic acid pathways. American Journal of Physiology-Endocrinology and Metabolism. 240(6). E645–E648. 1 indexed citations
19.
Ishibashi, Fukashi, Hisashi Hidaka, Rose M. Fields, B. V. Howard, & P. H. Bennett. (1981). Alloxan action on glucose metabolism in cultured fibroblasts. I. Stimulation and inhibition of glucose utilization. American Journal of Physiology-Endocrinology and Metabolism. 240(6). E640–E644. 2 indexed citations
20.
Ishibashi, Fukashi, et al.. (1980). Metabolism, 45Ca uptake and insulin releasing capacities of glucose and mannose. Metabolism. 29(7). 682–685. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Amey Holmes Breakdown of academic impact, for papers by R. Nagai Breakdown of academic impact, for papers by Toshihide Oizumi Breakdown of academic impact, for papers by P. H. N. Oomen Breakdown of academic impact, for papers by Cynthia K. Silbert Breakdown of academic impact, for papers by Takeyoshi Murano Breakdown of academic impact, for papers by Tetsuyuki Yasuda Breakdown of academic impact, for papers by MASAEI KAKIZAKI Breakdown of academic impact, for papers by Yehong Yang Breakdown of academic impact, for papers by Bianca Marmontel de Souza
Rankless by CCL
2026